Caltech - Amgen Collaborative Seminar

Overview of Discovery Research, Translational Sciences and Trends in Drug Delivery of Biologics

Tuesday, May 17th, 2016, 5-6 PM

Admission is free, registration is requested

Register Here

 

Amgen and Caltech are in their second year of Collaborative Partnership. This is an informative session by Amgen's top management about their Discovery Research.  Meet Amgen's R&D Management and scientists and find out how to forge collaboration with them. 

Where:  Caltech Hameetman Auditorium in the Cahill Center for Astronomy and Astrophysics

When: Tuesday, May 17th, 2016 (program from 5 p.m. to 6 p.m.; Q&A and reception following)

 

Amgen Speakers:

 

 Alexander Kamb, Sr. Vice President, Discovery Research, has over two decades of experience in the biotechnology industry.  Dr. Kamb received his A.B. from Harvard, his Ph.D. from Caltech and a postdoctoral fellow at UCSF with Harold Varmus and Robert Stroud.  In 1992 he joined Myriad Genetics and founded Arcaris in 1996, which was sold in 2003, whereupon he joined Novartis as Global Head of Oncology.  In 2006, Dr. Kamb joined Amgen to direct oncology research and in 2007 he took over the leadership of the Neurosciences Therapeutic Area. In 2011 he was promoted to Senior Vice President, and currently heads Amgen's entire Discovery Research organization (~1000 FTEs).

 

 

David Reese, Vice President, Translational Sciences and head for Oncology Global Development, is responsible for Medical Sciences. Dr. Reese joined Amgen in 2005 and, prior to assuming his current positions, served in various roles in Global Development and Medical Sciences.  Dr. Reese was educated at Harvard College and the University of Cincinnati College of Medicine. He completed training in Internal Medicine and Hematology/Oncology at the UCLA School of Medicine, and subsequently served on the faculty at UCLA and the University of California, San Francisco. 

 

 

Sheldon Moberg, Vice President, Drug Delivery, joined Amgen in 2011 to oversee the development of the company's broader device development strategy and is responsible for all device projects in Amgen's product portfolio.  Sheldon has over 20 years of experience in the development and commercialization of innovative medical devices.  Prior to Amgen, Sheldon held R&D leadership positions at Medtronic's Diabetes Division.  Sheldon earned a Master's degree in Mechanical Engineering from Purdue University and a Bachelor's degree in Mechanical Engineering from California Polytechnic State University, San Luis Obispo.